Co-crystal structure of perk bound to n-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1h-pyrazole-4-carboxamide inhibitor Deposition Author(s): Bellon, S.F. , Chen, H. , Long, A.M. , Shaffer, P.L.
Date: 2014-12-09 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 4X7H_A
Co-crystal structure of perk with 2-amino-n-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor Deposition Author(s): Chen, H. , Long, A.M. , Shaffer, P.L.
Date: 2014-12-09 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 4X7J_A
Co-crystal structure of perk bound to 4-{2-amino-3-[5-fluoro-2-(methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3h-pyrazol-3-one inhibitor Deposition Author(s): Chen, H. , Long, A.M. , Shaffer, P.L.
Date: 2014-12-09 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 4X7K_A
Co-crystal structure of perk bound to 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3h-pyrazol-3-one inhibitor Deposition Author(s): Chen, H. , Long, A.M. , Shaffer, P.L.
Date: 2014-12-09 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Homo Sapiens Sequences Data: 4X7L_A
Co-crystal structure of perk bound to 4-[2-amino-4-methyl-3-(2-methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3h-pyrazol-3-one inhibitor Deposition Author(s): Chen, H. , Long, A.M. , Shaffer, P.L.
Date: 2014-12-09 Method: X-RAY DIFFRACTION Resolution: 2.35 Å Organism(s): Homo Sapiens Sequences Data: 4X7N_A
Co-crystal structure of perk bound to 1-[5-(4-amino-2,7-dimethyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1h-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone inhibitor Deposition Author(s): Chen, H. , Long, A.M. , Shaffer, P.L.
Date: 2014-12-09 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 4X7O_A
Crystal structure of bace1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28 Deposition Author(s): Long, A.M. , Whittington, D.A.
Date: 2015-01-12 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 4XKX_A
Crystal structure of c-met in complex with (r)-5-(8-fluoro-3-(1-fluoro-1-(3-methoxyquinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole Deposition Author(s): Long, A.M. , Whittington, D.A.
Date: 2015-01-14 Method: X-RAY DIFFRACTION Resolution: 1.75 Å Organism(s): Homo Sapiens Sequences Data: 4XMO_A
Crystal structure of c-met in complex with (s)-5-(8-fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole Deposition Author(s): Long, A.M. , Whittington, D.A.
Date: 2015-02-02 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 4XYF_A
Crystal structure of c-met in complex with naphthyridinone inhibitor 5 Deposition Author(s): Long, A.M. , Whittington, D.A.
Date: 2015-11-24 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 5EYC_A